Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Futura MedicalSTU:GYX Days Payable is 0.00 as of Dec. 2025. The stock has 5 warning signs investors should review. Among 701 Biotechnology companies, Futura Medical ranks better than 83.74% on this metric.
The historical rank and industry rank for Futura Medical's Days Payable or its related term are showing as below:
STU:GYX'
s Days Payable Range Over the Past 10 Years
Min: 107.64 Med: 181.81 Max: 820.65
Current: 759.02
During the past 13 years, Futura Medical's highest Days Payable was 820.65. The lowest was 107.64. And the median was 181.81.
STU:GYX's Days Payable is ranked better than 83.74% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs STU:GYX: 759.02
Futura Medical's Days Payable
declined
from Dec. 2024 (83.86) to Dec. 2025 (0.00).
It may suggest that Futura Medicalaccelerated paying its suppliers.
Futura Medical Days Payable Related Terms
Futura Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Futura Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:GYX vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Futura Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Futura Medical Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Futura Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Futura Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Futura Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Futura Medical (STU:GYX) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Futura Medical and its competitors. Over the past decade, Futura Medical's Days Payable has ranged from 107.64 to 820.65. According to the industry distribution chart, Futura Medical ranks #114 out of 701 companies in the Biotechnology industry, placing it in the top 16.3%.
Is Futura Medical's Days Payable too high?
Futura Medical's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 107.64 to a high of 820.65. Based on the distribution chart, Futura Medical ranks #114 out of 701 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Futura Medical's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Futura Medical ranks #114 out of 701 companies for Days Payable. This places Futura Medical in the top 16% of its industry — outperforming the majority of peers. The industry median Days Payable is 112.84. Historically, Futura Medical's own Days Payable has ranged from 107.64 to 820.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Futura Medical and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Futura Medical's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Futura Medical stock overvalued right now?
Futura Medical (STU:GYX) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Futura Medical (STU:GYX), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:GYX has been successfully added to your 
